Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Feb 21, 2009; 15(7): 871-876
Published online Feb 21, 2009. doi: 10.3748/wjg.15.871
Published online Feb 21, 2009. doi: 10.3748/wjg.15.871
Table 3 Results of proportional hazards regression model
| Factor | Regression coefficient | Standard error | Wald | DOF | P | Exp (β) | 95% CI |
| Sex | -0.439 | 0.361 | 1.475 | 1 | 0.225 | 0.645 | 0.318-1.309 |
| Age | -0.151 | 0.342 | 0.194 | 1 | 0.659 | 0.860 | 0.440-1.682 |
| KPS | -1.449 | 0.342 | 17.906 | 1 | < 0.001 | 0.235 | 0.120-0.459 |
| Metastasis | 1.932 | 0.390 | 24.497 | 1 | < 0.001 | 6.902 | 3.212-14.833 |
| Pre-chemotherapy | -0.235 | 0.291 | 0.653 | 1 | 0.419 | 0.790 | 0.447-1.398 |
| Short-term effect | 0.972 | 0.254 | 14.610 | 1 | < 0.001 | 2.645 | 1.606-4.354 |
- Citation: Qin TJ, An GL, Zhao XH, Tian F, Li XH, Lian JW, Pan BR, Gu SZ. Combined treatment of oxaliplatin and capecitabine in patients with metastatic esophageal squamous cell cancer. World J Gastroenterol 2009; 15(7): 871-876
- URL: https://www.wjgnet.com/1007-9327/full/v15/i7/871.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.871